ziprasidone mesylate

Novadoz Pharmaceuticals LLC🇺🇸 United States

FDA Page

Effective Date: Aug 30, 2022
Approval ID: 90b35a26-ab65-4c39-b97f-55c8c0e34b0b
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ZIPRASIDONE MESYLATE FOR INJECTION safely and effectively. See full prescribing information for ZIPRASIDONE MESYLATE FOR INJECTION. ZIPRASIDONE MESYLATE for injection, for intramuscular use Initial U.S. Approval: 2001

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.